This page contains brief information about bleomycin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Bleomycin is approved to be used alone or with other drugs as palliative treatmentof:
- Hodgkin lymphoma.
- Non-Hodgkin lymphoma (NHL).
- Penile cancer.
- Squamous cell carcinoma of the cervix.
- Squamous cell carcinoma of the head and neck (SCCHN).
- Squamous cell carcinoma of the vulva.
- Testicular cancer.
Bleomycin is also approved to treat malignant pleural effusion and keep it from recurring (coming back).
Bleomycin is also being studied in the treatment of other types of cancer.
More About Bleomycin
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
MedlinePlus Information on Bleomycin – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
